Identification of Cuproptosis Clusters and Integrative Analyses in Parkinson’s Disease
暂无分享,去创建一个
Tingting Du | Tianshuo Yuan | Lin Shi | Chong Liu | Qiao Wang | Fangang Meng | Yuan Gao | Renpeng Li | Moxuan Zhang | Chun-sheng Han | Huizhi Wang | Wenjia Meng | Siyu Zhou | F. Meng
[1] Yuepu Pu,et al. Copper Induces Cognitive Impairment in Mice via Modulation of Cuproptosis and CREB Signaling , 2023, Nutrients.
[2] Houeto Jean-Luc. [Parkinson's disease]. , 2022, La Revue du praticien.
[3] Bilal Cakir,et al. Dyslexia associated gene KIAA0319 regulates cell cycle during human neuroepithelial cell development , 2022, Frontiers in Cell and Developmental Biology.
[4] Evan Z. Macosko,et al. Single-cell genomic profiling of human dopamine neurons identifies a population that selectively degenerates in Parkinson’s disease , 2022, Nature Neuroscience.
[5] K. Wakamatsu,et al. Neuromelanin in Parkinson’s Disease: Tyrosine Hydroxylase and Tyrosinase , 2022, International journal of molecular sciences.
[6] G. Kroemer,et al. Cuproptosis: a copper-triggered modality of mitochondrial cell death , 2022, Cell Research.
[7] Scott J. Dixon,et al. Copper-induced cell death , 2022, Science.
[8] T. Golub,et al. Copper induces cell death by targeting lipoylated TCA cycle proteins , 2022, Science.
[9] N. Dzamko,et al. Immune responses in the Parkinson's disease brain , 2022, Neurobiology of Disease.
[10] A. Casini,et al. Connecting copper and cancer: from transition metal signalling to metalloplasia , 2021, Nature Reviews Cancer.
[11] A. Strafella,et al. VMAT2 availability in Parkinson’s disease with probable REM sleep behaviour disorder , 2021, Molecular brain.
[12] Xuezhong Li,et al. Integrative analysis of potential biomarkers and immune cell infiltration in Parkinson’s disease , 2021, Brain Research Bulletin.
[13] Yuhu Zhang,et al. Significant Difference of Immune Cell Fractions and Their Correlations With Differential Expression Genes in Parkinson’s Disease , 2021, Frontiers in Aging Neuroscience.
[14] C. Vriend,et al. Dietary Approaches to Improve Efficacy and Control Side Effects of Levodopa Therapy in Parkinson's Disease: A Systematic Review , 2021, Advances in nutrition.
[15] D. Standaert,et al. CD4 T cells mediate brain inflammation and neurodegeneration in a mouse model of Parkinson's disease , 2021, Brain : a journal of neurology.
[16] Siguang Li,et al. Immune Profiling of Parkinson’s Disease Revealed Its Association With a Subset of Infiltrating Cells and Signature Genes , 2021, Frontiers in Aging Neuroscience.
[17] M. Greco,et al. Copper Dependent Modulation of α-Synuclein Phosphorylation in Differentiated SHSY5Y Neuroblastoma Cells , 2021, International journal of molecular sciences.
[18] E. Dardiotis,et al. Neurodegeneration and Inflammation—An Interesting Interplay in Parkinson’s Disease , 2020, International journal of molecular sciences.
[19] Qiong Zhang,et al. Expression profile of immune checkpoint genes and their roles in predicting immunotherapy response , 2020, Briefings Bioinform..
[20] E. Hirsch,et al. Ten Unsolved Questions About Neuroinflammation in Parkinson's Disease , 2020, Movement disorders : official journal of the Movement Disorder Society.
[21] F. C. Bennett,et al. Immune cell regulation of glia during CNS injury and disease , 2020, Nature Reviews Neuroscience.
[22] L. Bubacco,et al. Copper Ions and Parkinson’s Disease: Why Is Homeostasis So Relevant? , 2020, Biomolecules.
[23] R. Guillevin,et al. Circadian rhythms, Neuroinflammation and Oxidative Stress in the Story of Parkinson’s Disease , 2020, Cells.
[24] K. Double,et al. Oxidative stress in the aging substantia nigra and the etiology of Parkinson's disease , 2019, Aging cell.
[25] M. Hayes. Parkinson's Disease and Parkinsonism. , 2019, The American journal of medicine.
[26] D. Richardson,et al. The Role of the Antioxidant Response in Mitochondrial Dysfunction in Degenerative Diseases: Cross-Talk between Antioxidant Defense, Autophagy, and Apoptosis , 2019, Oxidative medicine and cellular longevity.
[27] D. Jiao,et al. Identification of Differentially Expressed Genes and Long Noncoding RNAs Associated with Parkinson's Disease , 2019, Parkinson's disease.
[28] Kazuto Kobayashi,et al. Human tyrosine hydroxylase in Parkinson’s disease and in related disorders , 2018, Journal of Neural Transmission.
[29] L. Sanders,et al. Alpha-synuclein: Pathology, mitochondrial dysfunction and neuroinflammation in Parkinson’s disease , 2018, Neurobiology of Disease.
[30] E. Benveniste,et al. Role of the JAK/STAT signaling pathway in regulation of innate immunity in neuroinflammatory diseases. , 2016, Clinical immunology.
[31] M. Okun,et al. Diagnosing Parkinson Disease , 2016, Continuum.
[32] D. Standaert,et al. Inhibition of the JAK/STAT Pathway Protects Against α-Synuclein-Induced Neuroinflammation and Dopaminergic Neurodegeneration , 2016, The Journal of Neuroscience.
[33] Matthew E. Ritchie,et al. limma powers differential expression analyses for RNA-sequencing and microarray studies , 2015, Nucleic acids research.
[34] A. Lang,et al. Pharmacological treatment of Parkinson disease: a review. , 2014, JAMA.
[35] D. Turnbull,et al. Ageing and Parkinson's disease: Why is advancing age the biggest risk factor?☆ , 2014, Ageing Research Reviews.
[36] S. Rivera-Mancía,et al. Copper and Copper Proteins in Parkinson's Disease , 2014, Oxidative medicine and cellular longevity.
[37] G. Getz,et al. Inferring tumour purity and stromal and immune cell admixture from expression data , 2013, Nature Communications.
[38] B. Lai,et al. Aging results in copper accumulations in glial fibrillary acidic protein‐positive cells in the subventricular zone , 2013, Aging cell.
[39] Ya Hui Hung,et al. Role of the P-Type ATPases, ATP7A and ATP7B in brain copper homeostasis , 2013, Front. Aging Neurosci..
[40] David N Hauser,et al. Mitochondrial dysfunction and oxidative stress in Parkinson's disease and monogenic parkinsonism , 2013, Neurobiology of Disease.
[41] Justin Guinney,et al. GSVA: gene set variation analysis for microarray and RNA-Seq data , 2013, BMC Bioinformatics.
[42] Guangchuang Yu,et al. clusterProfiler: an R package for comparing biological themes among gene clusters. , 2012, Omics : a journal of integrative biology.
[43] Philip L De Jager,et al. Parkinson's disease: genetics and pathogenesis. , 2011, Annual review of pathology.
[44] Matthew D. Wilkerson,et al. ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking , 2010, Bioinform..
[45] S. Horvath,et al. WGCNA: an R package for weighted correlation network analysis , 2008, BMC Bioinformatics.
[46] G. Raj,et al. How to build and interpret a nomogram for cancer prognosis. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[47] D. Thiele,et al. Mechanisms for copper acquisition, distribution and regulation. , 2008, Nature chemical biology.
[48] I. Onyango. Mitochondrial Dysfunction and Oxidative Stress in Parkinson’s Disease , 2008, Neurochemical Research.
[49] Robert W. Taylor,et al. High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease , 2006, Nature Genetics.
[50] Pablo Tamayo,et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[51] T. Montine,et al. Parkinson's disease is associated with oxidative damage to cytoplasmic DNA and RNA in substantia nigra neurons. , 1999, The American journal of pathology.
[52] Ash A. Alizadeh,et al. Profiling Tumor Infiltrating Immune Cells with CIBERSORT. , 2018, Methods in molecular biology.
[53] Tanya Barrett,et al. The Gene Expression Omnibus Database , 2016, Statistical Genomics.
[54] Andrew E. Jaffe,et al. Bioinformatics Applications Note Gene Expression the Sva Package for Removing Batch Effects and Other Unwanted Variation in High-throughput Experiments , 2022 .